A Clinical Trial of a Self-Management Education Program for People With Chronic Stable Angina

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2005 by University of Toronto.
Recruitment status was  Active, not recruiting
Information provided by:
University of Toronto
ClinicalTrials.gov Identifier:
First received: July 8, 2006
Last updated: NA
Last verified: November 2005
History: No changes posted
The purpose of this clinical trial was to determine the effectiveness of a supportive and educational self-management program for improving health-related quality of life (HRQOL), angina symptoms, and self-efficacy and resourcefulness to self-manage for chronic angina patients. 130 participants were enrolled in the trial for 3 months. The program, entitled the Chronic Angina Self-Management Program, (CASMP) was found effective for improving HRQOL, angina symptoms, and self-efficacy to manage symptoms, compared to usual care.

Condition Intervention Phase
Chronic Stable Angina
Behavioral: Psychoeducation
Phase 1

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: A Psychoeducation Trial for People With Chronic Stable Angina

Resource links provided by NLM:

Further study details as provided by University of Toronto:

Primary Outcome Measures:
  • SF36
  • Seattle Angina Questionnaire

Secondary Outcome Measures:
  • Self-Efficacy Scale
  • Self-Control Schedule

Estimated Enrollment: 130
Study Start Date: September 2003
Estimated Study Completion Date: November 2005

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Medical diagnosis of coronary artery disease CCS Class I-III Angina for at least 6 months Speak, read, understand English -

Exclusion Criteria:

MI/Bypass last 6 months CCS Class IV angina A major cognitive disorder -

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00350922

Canada, Ontario
University of Toronto
Toronto, Ontario, Canada, M5T 1P8
Sponsors and Collaborators
University of Toronto
Study Director: Judy H Watt-Watson, PhD University of Toronto
Principal Investigator: Michael H McGillion, PhD University of Toronto
  More Information

ClinicalTrials.gov Identifier: NCT00350922     History of Changes
Other Study ID Numbers: 452639 
Study First Received: July 8, 2006
Last Updated: July 8, 2006
Health Authority: Canada: Ethics Review Committee

Additional relevant MeSH terms:
Angina Pectoris
Angina, Stable
Cardiovascular Diseases
Chest Pain
Heart Diseases
Myocardial Ischemia
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms
Vascular Diseases

ClinicalTrials.gov processed this record on May 24, 2016